IMAX (IMAX) Q3 2026 earnings review
IMAX profit hits a record, but its theatre backlog shrinks
IMAX, the giant-screen cinema technology provider, turned Christopher Nolan's The Odyssey into the highest-grossing quarter in its history while its theatre installation backlog kept shrinking. Revenue rose 64% from a year ago as global ticket sales nearly doubled to $712 million, clearing most of the second-half box office target in a single quarter. Operating profit margin before interest, taxes, depreciation and one-offs reached 69%, and profit per share excluding one-offs and a one-time Canadian tax benefit more than tripled to $1.58 by our math.
| Revenue | $174.6M +64% from a year ago |
|---|---|
| Global ticket sales (box office) | $712M +94% from a year ago |
| Profit per share, excluding one-offs and tax reserve release | $1.58 $0.47 a year ago ($2.21 reported) |
| Theatre system backlog | 409 systems 421 last quarter and 478 a year ago |
⚖️ Verdict: 🟢 Bullish
The story got better because the quarter resolved the second-half box office hurdle and proved IMAX's cost structure can clear its 2028 profit margin goal of 50%. Nine-month Adjusted EBITDA margin now stands at 56%, up 11 percentage points from a year ago. One caution: the theatre backlog fell again to 409 systems because IMAX signed only 20 systems during the third quarter while installing 32, even though chief executive Rich Gelfond noted that signings passed 100 year-to-date in October.
The question now is whether record ticket sales will convert into a growing order book and steady 2027 installations once The Odyssey finishes its run. Either October's signings surge marks the start of a multi-quarter rebuilding of the 409-system backlog, or theatre chains remain reluctant to commit capital and 2027 installations slow down. Fourth-quarter backlog and signings will settle it.
🐂 Bull Case
Operating Leverage Lifted Margin Past the 2028 Target
Going into the quarter, a major question was why IMAX kept its 2026 profit margin plan flat around 45% while promising over 50% by 2028. Chief executive Rich Gelfond said this quarter's record margins show "the unique strength of our model", because cinema ticket sales above a fixed threshold flow straight into profit.
- Adjusted EBITDA margin (profit before interest, taxes, depreciation and one-offs): 69.3%, up 20.7 percentage points from a year ago
- Cost of making and servicing films and systems: 27.6% of revenue, down 9.3 percentage points by our math
- Selling and overhead expenses: 22.4% of revenue, down 9.7 percentage points by our math
Two straight quarters of expanding margins have now pushed the nine-month Adjusted EBITDA margin to 55.6%, up 10.7 percentage points from a year ago. That clears both the 45% floor for 2026 and the 50% goal for 2028, proving the cost base can deliver the long-term target whenever ticket sales cooperate.
What to watch: the fourth-quarter Adjusted EBITDA margin alongside Dune: Part Three ticket sales. Holding the full-year figure above 50% would confirm that IMAX reached its 2028 profitability goal two years early.
The Odyssey Carried the Full-Year Box Office Plan
IMAX needed roughly $855 million of second-half ticket sales across its theatres to meet its $1.4 billion full-year plan, a 22% jump against its toughest comparison on record. Christopher Nolan's The Odyssey, shot entirely with IMAX film cameras, cleared nearly that entire second-half hurdle in a single quarter.
Global ticket sales at IMAX theatres rose 94% from a year ago to $712 million, with The Odyssey contributing $538 million in the quarter and over $550 million worldwide to date. The film captured more than 30% of its total global box office on IMAX screens, lifting Content Solutions revenue (fees for remastering and distributing films) by 110% to $94.0 million and Technology rentals revenue by 78% to $41.4 million.
By our math, nine-month global ticket sales have reached $1.26 billion, leaving just $144 million in the fourth quarter to hit the $1.4 billion full-year target — a 57% drop from last year's fourth quarter even with Dune: Part Three opening in December. What to watch: fourth-quarter ticket sales and the number of 70mm film titles confirmed for 2027, where management added the original Star Wars to its 70mm lineup.
Positives this quarter didn't test
Two standing growth drivers moved forward in the headline numbers, but the earnings release did not include the detailed tables needed to measure their progress.
- International network expansion: Gelfond cited strong signings across priority Rest of World markets and 65% new locations year-to-date, and the quarterly filing's geographic breakdown will show how many screens opened in high-ticket-price markets.
- Brand extensions and merchandise: All Other revenue (which houses film merchandise and home-entertainment licensing) jumped 137% from a year ago to $3.3 million by our math, and the quarterly filing or conference call will show how much came from Odyssey merchandise.
🐻 Bear Case
Theatre Backlog Shrank Despite Record Box Office
Gelfond said box office momentum is "fueling sales activity with exhibitors around the world, with our team delivering more than 100 signings for IMAX systems worldwide year-to-date". However, that 100-plus figure includes deals signed in October after the quarter closed, while the third-quarter table shows the order book still shrinking.
- System backlog (signed theatre deals waiting to be installed): 409 systems, down from 421 last quarter and 478 a year ago
- Third-quarter system signings: 20 systems (79 across the first nine months, vs 142 a year ago)
- Third-quarter system installations: 32 systems, down from 38 a year ago (89 across the first nine months, vs 95 a year ago)
Because IMAX installed 32 systems while signing only 20 during the quarter, it drew down its backlog by another 12 units. Furthermore, hitting the full-year target of 160 to 175 installations now requires 71 to 86 installations in the fourth quarter by our math, up from 65 in the fourth quarter of 2025, which will drain the 409-unit backlog further unless fourth-quarter signings surge.
What to watch: fourth-quarter system signings and year-end backlog. A year-end backlog below 380 systems would mean theatre chains are still hesitating to commit capital despite record ticket sales.
One Film Drove Three-Quarters of Ticket Sales
"What IMAX achieved goes beyond simply a ‘great quarter’ and transcends the many records we shattered in the period," Gelfond said, calling the result an awakening to the platform. Yet the numbers show that a single director's film did almost all the work.
By our math, The Odyssey generated 75.6% of IMAX's $712 million third-quarter box office ($538 million), while the second-biggest title, Spider-Man: Brand New Day, brought in $58 million. Every other film combined produced $174 million in ticket sales, which is 53% below the $367.6 million IMAX made across its entire slate in the third quarter of 2025.
That concentration creates a tough comparison for the third quarter of 2027, when no Christopher Nolan film is on the calendar. What to watch: first-half 2027 ticket sales per screen across non-70mm releases, which will show whether audiences are coming for the IMAX format itself or only for Nolan events.
One-Off Tax Benefit Inflated Headline Profit
IMAX highlighted that its profit per share excluding one-offs rose 370% from a year ago to $2.21, eclipsing any full year in company history. However, that figure includes a large one-time tax gain while stripping out a write-down.
During the quarter, IMAX released $36.7 million ($0.63 per share) of Canadian tax reserves because higher profits allow it to use past tax losses, and management left that gain inside both GAAP and non-GAAP profit. At the same time, the non-GAAP profit calculation removed a $6.8 million goodwill write-down ($0.12 per share). By our math, excluding the $0.63 tax gain brings clean profit per share to $1.58 — still up 236% from $0.47 a year ago, so operating profit was genuinely strong, but 29% lower than the headline number.
What to watch: the effective tax rate in the fourth quarter, when the one-time Canadian reserve release will not repeat and tax expense returns to a normal cash rate.
Risks this quarter didn't answer
Three standing risks from prior quarters could not be fully checked because their disclosures live in the quarterly Form 10-Q filing rather than the earnings release.
- Greater China credit quality and revenue: credit loss expense doubled from a year ago to $1.2 million and the backlog footnote still carries the "restructuring of certain contracts resulting in cancellation of backlog for 17 system locations deemed mutually to no longer be beneficial to IMAX and its exhibition customers", while China revenue and overdue receivables await the 10-Q.
- Tariffs and shipping costs: equipment sales revenue dipped 2.5% from a year ago to $18.9 million on two fewer sales installations, and the 10-Q will show if tariff costs weighed on hardware margins.
- Canada Revenue Agency tax audit: the release did not update the tax authority's proposal letter on prior-year international matters, which will be updated in the 10-Q tax footnote.
💲 Other KPIs
Cash generated after capital spending rose 41.2% from a year ago to $77.4 million in the third quarter by our math (44.3% of revenue), bringing the nine-month total to $100.3 million. The theatre technology group used that cash to pay off all $38.8 million of its credit line, cutting net debt (total debt minus cash) from $131.8 million last quarter to $43.1 million by our math.
Money owed by studio and theatre customers rose 21.4% from last quarter and 28.6% from year-end to $139.0 million by our math, absorbing $33.3 million of operating cash across the first nine months. The increase follows the late-quarter international openings of The Odyssey in China, South Korea and Japan, which turn into cash collections in the fourth quarter.
Diluted shares rose 4.4% from a year ago and 2.5% from last quarter to 58.0 million. The share count increased because IMAX's $250 million of convertible notes due 2030 became dilutive under accounting rules, while the company bought back zero shares in the quarter after spending $13.7 million on buybacks in the second quarter.
❓ Key Questions
Why did the release omit updated 2026 full-year targets?
Through thefirst nine months, global ticket sales reached $1.26 billion against the $1.4 billion full-year plan, and Adjusted EBITDA margin reached 55.6% against the 45% floor. Management did not print updated full-year targets in the release, leaving open how high the new bar sits.
How many system signings closed in October versus Q3?
Gelfond highlighted over 100 system signings year-to-date in the text, but the third-quarter table shows only 79 signings through September 30 (and 20 in Q3). Investors need to know whether the 21-plus October signings were new locations or upgrades, and when they install.
Did Greater China revenue and overdue receivables improve on The Odyssey?
First-half China revenue fell 40% from a year ago and overdue receivables in China forced higher credit reserves in the second quarter. With The Odyssey opening in China on August 14 and credit loss expense still at $1.2 million in Q3, did Chinese exhibitor collections improve?
How much did 70mm film prints and merchandise add to Q3?
Content Solutions gross margin hit a record 76.3% and All Other revenue rose 137% to $3.3 million. Management has not disclosed the exact take-rate uplift on the 41 film-projector locations or how much revenue and profit came from Odyssey merchandise drops.